Sirna Therapeutics, Inc.

Sirna Therapeutics, Inc.

Sirna Therapeutics, Inc.

Overview
Date Founded

1992

Headquarters

1700 Owens Street,4th floor,San Francisco, CA 94158

Type of Company

Private

Industries

Other Business & Consulting Services
Medical Products & Equipment
Hospitals & Patient Services
Pharmaceuticals
Biotechnology

Company Description

Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA.

Executives & Employees

Co-Founder

Director

Paths to Sirna Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Sirna Therapeutics, Inc.
Recent Transactions
Details Hidden

Alnylam Pharmaceuticals, Inc. purchases Sirna Therapeutics, Inc. from Merck & Co., Inc.

Details Hidden

Merck & Co., Inc. purchases Sirna Therapeutics, Inc.

Details Hidden

Sirna Therapeutics, Inc. issued Common Stock

Transaction Advisors
Underwriter

Advised onSirna Therapeutics, Inc. issued Common Stock

Underwriter

Advised onSirna Therapeutics, Inc. issued Common Stock

Underwriter

Advised onSirna Therapeutics, Inc. issued Common Stock

Director & President

Advised onMerck & Co., Inc. purchases Sirna Therapeutics, Inc.

Legal Advisor

Advised onMerck & Co., Inc. purchases Sirna Therapeutics, Inc.

Legal Advisor

Advised onMerck & Co., Inc. purchases Sirna Therapeutics, Inc.

Non-Profit Donations & Grants
Investments
Details Hidden

Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA.

Investors
Details Hidden

Sprout's investment focus is in communications, software, services & e-commerce and healthcare technology sectors. The firm seeks existing or potential market leaders within these sectors and invests in companies at all stages from start-up through buyout whose enterprise value ranges from $50 million to over $2 billion.

Details Hidden

Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations.

Details Hidden

Venrock helps entrepreneurs build some of the world's most disruptive, successful companies. They partner with entrepreneurs who have grand ambitions and help's them in almost every dimension of building their company: hiring, strategy, financing, scaling, introductions and managing a great exit. The firm targets to invest in companies operating in the fields of technology & health care sectors and provides financing for early stage capital requirements.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sirna Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sirna Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Sirna Therapeutics, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/sirna-therapeutics-inc-21713
  • https://relationshipscience.com/organization/sirna-therapeutics-inc-21713